Hochman Cole Investment Advisors’s Definium Therapeutics DFTX Stock Holding History

Hochman Cole Investment Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$74K	Buy	+2,117	New	+$91.5K	0.03%	128

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return

Hochman Cole Investment Advisors's DFTX Position: Q3 2021 in Review

Hochman Cole Investment Advisors opened a new position in Definium Therapeutics (DFTX) in Q3 2021: 2,117 shares worth $74K. The stake represents 0.03% of the portfolio and ranks #128 among its holdings.

174 funds tracked by Wall St. Rank hold DFTX as of Q3 2021.

Hochman Cole Investment Advisors held 2,117 shares of Definium Therapeutics worth $74K as of Q3 2021.
Definium Therapeutics was a new Hochman Cole Investment Advisors position in Q3 2021.
Definium Therapeutics made up 0.03% of Hochman Cole Investment Advisors's portfolio in Q3 2021, its #128 holding.
174 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2021.

Based on Hochman Cole Investment Advisors's 13F filing for Q3 2021, filed 20 Oct 2021.